Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Integrated Drug Discovery

Product Image
Product Description

Success in drug discovery depends on a deep understanding of the physiological context of a disease and on the knowledge of the properties that make a molecule into a therapeutically and commercially successful drug.

Our medicinal chemists use synthetic chemistry as a tool to solve problems in biology, pharmacology, and medicine. The experience and creativity of our medicinal chemistry team play a key role in advancing your project and ensuring ultimate success.

Selcia Discovery applies a consultative approach to ensure thorough understanding of the project objectives and deliverable. Key to success is a comprehensive grasp on your requirements and then providing high quality compounds to help you move your project forward.

Our approach can be tailored to the specialist needs of academic institutions and small biotechs where we can be the medicinal chemistry resource supporting you with the following key skills

  • Medicinal chemistry expertise
  • Computational chemistry tools
  • Synthetic excellence ensuring speedy execution of synthesis programmes
  • Patent knowledge
  • In-house biology and in vitro ADME
  • Managing outsourced studies
  • Project management

Product Integrated Drug Discovery
Company Selcia Discovery Services
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Selcia Discovery Services
Fyfield Business & Research Park, Fyfield Road, Ongar, Essex CM5 0GS UK

Tel: +44 (0) 1277 367 000
Fax: +44 (0) 1277 367 099

Scientific News
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Drug Leads Identified to Combat Heart Disease
Using three supercomputers, researchers surveyed protein structures through accelerated molecular dynamics.
Accelerating the Path to Molecules for Medicine
Researchers convert carbon-hydrogen bonds into nitriles - converting organic molecules into components of medicines.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos